Carolyn L. Ruby

1.4k total citations · 1 hit paper
19 papers, 1.1k citations indexed

About

Carolyn L. Ruby is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Carolyn L. Ruby has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Organic Chemistry. Recurrent topics in Carolyn L. Ruby's work include Microbial Natural Products and Biosynthesis (6 papers), Synthesis and characterization of novel inorganic/organometallic compounds (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Carolyn L. Ruby is often cited by papers focused on Microbial Natural Products and Biosynthesis (6 papers), Synthesis and characterization of novel inorganic/organometallic compounds (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Carolyn L. Ruby collaborates with scholars based in United States, Spain and Japan. Carolyn L. Ruby's co-authors include Patrice H. Gibbons, Keith M. Gewain, Douglas J. MacNeil, Tanya MacNeil, Gabe Dezeny, James Occi, L. Riesel, Marvin D. Schulman, Sheo B. Singh and Ziqiang Guan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Antimicrobial Agents and Chemotherapy and Gene.

In The Last Decade

Carolyn L. Ruby

18 papers receiving 1.1k citations

Hit Papers

Analysis of Streptomyces avermitilis genes required for a... 1992 2026 2003 2014 1992 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolyn L. Ruby United States 13 729 715 264 213 187 19 1.1k
Keith M. Gewain United States 11 742 1.0× 800 1.1× 224 0.8× 235 1.1× 162 0.9× 12 1.1k
Fiona Flett United Kingdom 17 752 1.0× 899 1.3× 174 0.7× 210 1.0× 153 0.8× 28 1.2k
Ralph H. Lambalot United States 11 748 1.0× 1.1k 1.5× 268 1.0× 133 0.6× 180 1.0× 11 1.4k
Kay Fowler United Kingdom 6 1.1k 1.5× 1.1k 1.5× 273 1.0× 235 1.1× 230 1.2× 6 1.6k
Gabe Dezeny United States 6 547 0.8× 521 0.7× 156 0.6× 140 0.7× 135 0.7× 7 767
Sylvie Lautru France 18 922 1.3× 1.1k 1.6× 308 1.2× 175 0.8× 225 1.2× 29 1.5k
Axel Trefzer Germany 16 774 1.1× 917 1.3× 406 1.5× 121 0.6× 215 1.1× 21 1.3k
Meifeng Tao China 26 1.1k 1.5× 1.1k 1.5× 311 1.2× 203 1.0× 301 1.6× 64 1.6k
Bertrand Aigle France 23 923 1.3× 914 1.3× 255 1.0× 228 1.1× 321 1.7× 48 1.3k
R G Summers United States 12 514 0.7× 677 0.9× 205 0.8× 144 0.7× 132 0.7× 16 949

Countries citing papers authored by Carolyn L. Ruby

Since Specialization
Citations

This map shows the geographic impact of Carolyn L. Ruby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn L. Ruby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn L. Ruby more than expected).

Fields of papers citing papers by Carolyn L. Ruby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn L. Ruby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn L. Ruby. The network helps show where Carolyn L. Ruby may publish in the future.

Co-authorship network of co-authors of Carolyn L. Ruby

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn L. Ruby. A scholar is included among the top collaborators of Carolyn L. Ruby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn L. Ruby. Carolyn L. Ruby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Herath, Kithsiri, Hiranthi Jayasuriya, Ziqiang Guan, et al.. (2005). Anthrabenzoxocinones from Streptomyces sp. as Liver X Receptor Ligands and Antibacterial Agents. Journal of Natural Products. 68(9). 1437–1440. 35 indexed citations
2.
Singh, Sheo B., John G. Ondeyka, Carolyn L. Ruby, et al.. (2004). Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease. Biochemical and Biophysical Research Communications. 324(1). 108–113. 33 indexed citations
3.
Singh, Sheo B., Deborah L. Zink, George A. Doss, et al.. (2004). Citrafungins A and B, Two New Fungal Metabolite Inhibitors of GGTase I with Antifungal Activity.. ChemInform. 35(24).
4.
Singh, Sheo B., Deborah L. Zink, George A. Doss, et al.. (2004). Citrafungins A and B, Two New Fungal Metabolite Inhibitors of GGTase I with Antifungal Activity. Organic Letters. 6(3). 337–340. 20 indexed citations
5.
Wilson, Kenneth E., Nancy N. Tsou, Ziqiang Guan, et al.. (2000). Isolation and structure elucidation of coleophomones A and B, novel inhibitors of bacterial cell wall transglycosylase. Tetrahedron Letters. 41(45). 8705–8709. 38 indexed citations
6.
Roach, Claudia, et al.. (1994). Mutants of Streptomyces cattleya defective in the synthesis of a factor required for thienamycin production.. The Journal of Antibiotics. 47(9). 992–1000. 4 indexed citations
7.
Arison, Byron H., et al.. (1993). A cofactor for thienamycin biosynthesis produced by a blocked mutant ofStreptomyces cattleya. Journal of Industrial Microbiology & Biotechnology. 12(1). 66–67. 4 indexed citations
8.
MacNeil, Douglas J., Keith M. Gewain, Carolyn L. Ruby, et al.. (1992). Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector. Gene. 111(1). 61–68. 635 indexed citations breakdown →
9.
MacNeil, Douglas J., James Occi, Keith M. Gewain, et al.. (1992). Complex organization of the Streptomyces avermitilis genes encoding the avermectin polyketide synthase. Gene. 115(1-2). 119–125. 156 indexed citations
10.
Vinci, Victor A., et al.. (1991). Mutants of a lovastatin-hyperproducingAspergillus terreus deficient in the production of sulochrin. Journal of Industrial Microbiology & Biotechnology. 8(2). 113–119. 48 indexed citations
11.
Blizzard, Timothy A., Carolyn L. Ruby, Helmut Mrozik, Franz A. Preiser, & Michael H. Fisher. (1989). Brine shrimp (Artemia salina) as a convenient bioassay for avermectin analogs.. The Journal of Antibiotics. 42(8). 1304–1307. 28 indexed citations
12.
Schulman, Marvin D. & Carolyn L. Ruby. (1987). Methylation of demethylavermectins. Antimicrobial Agents and Chemotherapy. 31(6). 964–965. 9 indexed citations
13.
Schulman, Marvin D., et al.. (1987). "Streptomyces avermitilis" mutants defective in methylation of avermectins. Antimicrobial Agents and Chemotherapy. 31(5). 744–747. 19 indexed citations
14.
Foor, F, Gary P. Roberts, Nancy R. Morin, et al.. (1985). Isolation and characterization of the Streptomyces cattleya temperate phage TG1. Gene. 39(1). 11–16. 28 indexed citations
15.
Riesel, L., et al.. (1977). Ester der Imidodiphosphorsäure. Zeitschrift für anorganische und allgemeine Chemie. 430(1). 227–233. 23 indexed citations
16.
Riesel, L., et al.. (1977). Untersuchungen zur Phosphorylierung von Imidodiphosphorsäurederivaten. Zeitschrift für anorganische und allgemeine Chemie. 437(1). 275–281. 4 indexed citations
17.
Riesel, L., et al.. (1977). Zur Konstitution der Trimethylsilylderivate von Imidodiphosphorylverbindungen. Zeitschrift für anorganische und allgemeine Chemie. 433(1). 200–206. 12 indexed citations
18.
Dulaney, Eugene L. & Carolyn L. Ruby. (1977). In vitro development of resistance to fosfomycin.. The Journal of Antibiotics. 30(3). 252–261. 4 indexed citations
19.
Schaefler, S., et al.. (1976). Minocycline Resistance in Staphylococcus aureus: Effect on Phage Susceptibility. Antimicrobial Agents and Chemotherapy. 9(4). 600–613. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026